
BiomX Inc.
AMEX:PHGE
0.53 (USD) • At close November 27, 2023
Overzicht | Financiële gegevens
Bedrijfsnaam | BiomX Inc. |
Symbool | PHGE |
Munteenheid | USD |
Prijs | 0.41 |
Beurswaarde | 18,851,677 |
Dividendpercentage | 0% |
52-weken bereik | 0.132 - 0.69 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. Jonathan Eitan Solomon MBA |
Website | https://www.biomx.com |
An error occurred while fetching data.
Over BiomX Inc.
BiomX Inc., a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibrosis (CF), atopic
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)